Cooper Cancer Center is a clinical research site located in Camden, New Jersey, United States 08103.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Cooper Cancer Center has participated in 1 clinical trials.
Therapeutic areas: Advanced, Metastatic Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cooper Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cooper Cancer Center has 1 clinical trials on record. Their work covers Advanced, Metastatic Breast Cancer.
Cooper Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.